ThinkCyte Introduces MorphoScan Cloud
In a significant step towards advancing cell analysis and morphology, ThinkCyte has announced the pre-commercial launch of its innovative platform, MorphoScan Cloud. This new cloud-based solution promises to enhance the accessibility, processing speed, and analytical capability of cell morphology data analysis using artificial intelligence. This launch aligns with the ongoing 38th Annual Congress of the International Society for the Advancement of Cytometry (CYTO 2025), being held in Denver, Colorado from May 31 to June 4.
ThinkCyte has established itself as a leader in the life sciences sector, focusing on pioneering technologies for AI-powered cell sorting and analysis. With MorphoScan Cloud, the company aims to significantly enrich the user experience connected to its flagship product, VisionSort. This platform, renowned for its morphometric cell analysis, now encompasses secure cloud storage and supports multi-user access. This feature facilitates collaborative research by allowing teams across different locations to centralize, share, and analyze data generated from VisionSort more effectively.
The suite of analytical tools integrated within MorphoScan Cloud has been specifically designed to unearth deeper biological insights from complex cellular data. Researchers can apply either supervised or unsupervised learning techniques to their datasets, leveraging advanced algorithms, including deep learning methods, to maximize the potential of their research.
Waichiro Katsuda, CEO of ThinkCyte, emphasized the platform's capabilities along with its intelligent design, stating, "With MorphoScan Cloud, we're providing our customers with more than just storage - we're offering an intelligent platform that transforms how research teams engage with cellular data. By merging the innovative biology insights from VisionSort with advanced AI analytics and cloud accessibility, we aim to enhance data analysis workflows, speed up discoveries, and foster innovation in life sciences."
MorphoScan Cloud's launch marks a significant leap in the company's ongoing commitment to delivering advanced morphometric solutions tailored for life science research. Not only does it allow researchers to store data securely, but it also provides the computational power needed to analyze complex datasets in ways that were previously challenging.
For attendees at CYTO 2025, this innovation provides an excellent opportunity to experience firsthand what MorphoScan Cloud has to offer. Visitors can engage with ThinkCyte's team at booth #627 to explore the platform's features and applications. Details regarding MorphoScan Cloud can also be found on ThinkCyte's official webpage.
About ThinkCyte
Established in 2016, ThinkCyte operates out of Tokyo, Japan, and Redwood City, California. The company is at the forefront of biotechnology, specializing in developing groundbreaking research platforms combining various technologies to facilitate innovative life sciences research, diagnostics, and therapy development. Notably, ThinkCyte introduced Ghost Cytometry™, a proprietary AI-based, label-free technology for cell analysis and sorting. The company collaborates with several leading global biopharmaceutical organizations and prestigious academic institutions to push the boundaries of research in the field.
For additional information about ThinkCyte and its latest offerings, you can visit their website
here.